Company News
Viyash Completes €16.98M BioForLife Italia Acquisition
Viyash Scientific's subsidiary Alivira completes 100% acquisition of BioForLife Italia S.r.l. for a total consideration of €16.976 million.
Base purchase consideration is €15.0 million with an additio